IPP Bureau
Cayman, Akadeum to revolutionize cell isolation for cell and gene therapy
By IPP Bureau - September 29, 2025
Lilly opens biotech in San Diego
By IPP Bureau - September 29, 2025
82,514 sq ft facility to host up to 15 biotech companies, fueling the development of next-generation medicines
Lupin acquires VISUfarma to strengthen specialty ophthalmology portfolio
By IPP Bureau - September 29, 2025
DINAMIQS inaugurates new cGMP viral vector manufacturing facility in Switzerland
By IPP Bureau - September 29, 2025
The new site enables end-to-end production of viral vector gene therapies
Apollo signs agreement to manage internal security force hospital in Iraq
By IPP Bureau - September 29, 2025
The collaboration is expected to facilitate access to world-class treatments and specialised care for Iraqi personnel
Infinitus launches MCP server to bring standardized AI interoperability to healthcare
By IPP Bureau - September 29, 2025
New infrastructure makes it possible for healthcare organizations to integrate AI agents seamlessly into critical workflows like benefit verification and prior authorization
Air Liquide bags contract in Spain to care for patients living with respiratory conditions at home
By IPP Bureau - September 27, 2025
Air Liquide will provide care for people living with respiratory diseases such as chronic obstructive pulmonary disease (COPD) and sleep apnea
Moderna opens manufacturing and R&D facility in UK
By IPP Bureau - September 27, 2025
The Moderna Innovation and Technology Centre in Harwell, Oxfordshire is now fully operational and Moderna is licensed to supply British-made COVID-19 vaccines to the UK population
Fujifilm Biotechnologies opens cell culture manufacturing site in North Carolina
By IPP Bureau - September 26, 2025
Represents one of the largest cell culture biomanufacturing sites in North America, which will employ 1,400 people by 2031
The Lancet Regional Health publishes pivotal phase 3 clinical study on Miqnaf
By IPP Bureau - September 26, 2025
Bartronics India acquires 15% stake in Huwel Life Sciences for Rs. 50 Cr
By IPP Bureau - September 26, 2025
BIL also holds an option to increase its equity stake by an additional 15%
FDA approves Alembic’s Paroxetine ER tablets
By IPP Bureau - September 26, 2025
Paroxetine Extended-Release Tablets USP, 25 mg and 37.5 mg, are indicated for the treatment of major depressive disorder
_LOGO.jpg "DMMA warns regulatory burden threatening Gujarat’s pharma MSMEs"){kind=logo}
DMMA warns regulatory burden threatening Gujarat’s pharma MSMEs
By IPP Bureau - September 26, 2025
The association called for an end to the constant issuance of regulatory circulars that make operations unpredictable and capital-intensive.
FUJIFILM India installs DR X-ray system at CHC Dholera
By IPP Bureau - September 26, 2025
The CSR initiative will offer Digital Radiology X-Ray service to Dholera and 33 surrounding villages in the region
Pi Health to deliver clinical research services for GSK’s Phase 2 oncology trial
By IPP Bureau - September 26, 2025
Physician-led Pi Health has demonstrated capabilities to dramatically reduce clinical trial timelines and administrative burden, while increasing data quality
